Klugman KP - Search Results

1

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.

Cohen C, von Mollendorf C, de Gouveia L, Lengana S, Meiring S, Quan V, Nguweneza A, Moore DP, Reubenson G, Moshe M, Madhi SA, Eley B, Hallbauer U, Finlayson H, Varughese S, O'Brien KL, Zell ER, Klugman KP, Whitney CG, von Gottberg A; South African IPD Case-Control Study Group. Cohen C, et al. Among authors: klugman kp. Lancet Glob Health. 2017 Mar;5(3):e359-e369. doi: 10.1016/S2214-109X(17)30043-8. Epub 2017 Jan 28. Lancet Glob Health. 2017. PMID: 28139443 Free article.

2

Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective.

Koornhof HJ, Wasas A, Klugman K. Koornhof HJ, et al. Clin Infect Dis. 1992 Jul;15(1):84-94. doi: 10.1093/clinids/15.1.84. Clin Infect Dis. 1992. PMID: 1617077 Review.

3

Antibiotic-resistant pneumococcal disease in South African children.

Friedland IR, Klugman KP. Friedland IR, et al. Among authors: klugman kp. Am J Dis Child. 1992 Aug;146(8):920-3. doi: 10.1001/archpedi.1992.02160200042023. Am J Dis Child. 1992. PMID: 1636657

4

Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986.

Klugman KP, Koornhof HJ. Klugman KP, et al. J Infect Dis. 1988 Nov;158(5):956-64. doi: 10.1093/infdis/158.5.956. J Infect Dis. 1988. PMID: 3183429

5

The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K. Jones N, et al. AIDS. 1998 Nov 12;12(16):2177-84. doi: 10.1097/00002030-199816000-00013. AIDS. 1998. PMID: 9833859

6

Emergence of drug resistance. Impact on bacterial meningitis.

Klugman KP, Madhi SA. Klugman KP, et al. Infect Dis Clin North Am. 1999 Sep;13(3):637-46, vii. doi: 10.1016/s0891-5520(05)70098-2. Infect Dis Clin North Am. 1999. PMID: 10470559 Review.

7

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.

Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Mbelle N, et al. Among authors: klugman kp. J Infect Dis. 1999 Oct;180(4):1171-6. doi: 10.1086/315009. J Infect Dis. 1999. PMID: 10479145 Clinical Trial.

8

Pneumococcal conjugate vaccine--prospects for intervention in children.

Madhi SA, Klugman KP. Madhi SA, et al. Among authors: klugman kp. Semin Respir Infect. 1999 Sep;14(3):285-94. Semin Respir Infect. 1999. PMID: 10501316 Review. No abstract available.

9

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG. Heffelfinger JD, et al. Among authors: klugman kp. Arch Intern Med. 2000 May 22;160(10):1399-408. doi: 10.1001/archinte.160.10.1399. Arch Intern Med. 2000. PMID: 10826451

10

Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1.

Madhi SA, Schoub B, Simmank K, Blackburn N, Klugman KP. Madhi SA, et al. Among authors: klugman kp. J Pediatr. 2000 Jul;137(1):78-84. doi: 10.1067/mpd.2000.105350. J Pediatr. 2000. PMID: 10891826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters